ADPT Stock Analysis: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$21.19
-1.18 (-5.27%)
▼
5d:
+4.64%
30d:
+39.96%
90d:
+46.85%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $21.19, which is considered extended relative to its 30-day fair value range of $15.39 to $19.99.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $17.00, while resistance sits at $22.80. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $17.00, while resistance sits at $22.80. Short-term momentum is weak, with the stock down 5.3% recently.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.39 -
$19.99
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
Protect Your Profits
Holding ADPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.0% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.3%)
- NEUTRAL: Near Wall St target ($20.29)
Trading Range Analysis
30-Day Trading Range
$15.39 -
$19.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.00
Resistance Level
$22.80
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-83.79
Wall Street Target
$20.29
(-4.3%)
Revenue Growth (YoY)
35.1%
Profit Margin
-16.8%
Share & Embed Analysis
Last updated: July 02, 2026 10:43 PM ET
Data refreshes hourly during market hours. Next update: 11:43 PM
Data refreshes hourly during market hours. Next update: 11:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Rubinstein
SELL
19060 shares
2026-04-24
Julie Rubinstein
SELL
19060 shares
2026-04-22
Julie Rubinstein
SELL
30941 shares
2026-04-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
Advanced ADPT Option Strategies
Professional options setups generated by AI based on today's ADPT price and gamma walls.
